Brief: Evolus Q3 Net Income USD -19.17 Million
06/11/2024 21:05
Nov 06 (Reuters) - Evolus outlook FY sales USD 260-266 million. * outlook FY sales growth 29-32%
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe